Ifg Advisory, LLC Gilead Sciences, Inc. Transaction History

Ifg Advisory, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $308,718 - $337,318	-4,864 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$60.0 - $68.46 $63,840 - $72,841	1,064 Added 28.0%	4,864 $314,000
Q4 2020 Feb 08, 2021	BUY	$56.65 - $64.55 $19,997 - $22,786	353 Added 10.24%	3,800 $221,000
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $2,980 - $3,747	-48 Reduced 1.37%	3,447 $217,000
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $2,676 - $3,108	37 Added 1.07%	3,495 $268,000
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $15,156 - $19,413	-242 Reduced 6.54%	3,458 $258,000
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $29,392 - $32,331	-477 Reduced 11.42%	3,700 $240,000
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $51,195 - $56,511	-819 Reduced 16.39%	4,177 $264,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $17,385 - $19,495	281 Added 5.96%	4,996 $337,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $72,597 - $81,328	-1,161 Reduced 19.76%	4,715 $306,000
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $278,484 - $363,400	-4,600 Reduced 43.91%	5,876 $367,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $174,921 - $193,669	-2,454 Reduced 18.98%	10,476 $808,000
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $48,854 - $56,987	-753 Reduced 5.5%	12,930 $915,000
Q1 2018 Apr 26, 2018	SELL	$72.84 - $88.8 $88,136 - $107,448	-1,210 Reduced 8.12%	13,683 $0
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $900,260 - $1.06 Million	12,653 Added 564.87%	14,893 $1.07 Million
Q4 2017 Jan 29, 2018	BUY	$71.15 - $83.52 $159,376 - $187,084	2,240	2,240 $1.16 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.